Wizards guard Bilal Coulibaly is day-to-day with an illness and questionable for Wednesday's game against the Hawks. Washington has not played a game without him this season, so his status matters for the rotation.
What happened
Wizards guard Bilal Coulibaly appeared on the injury report Wednesday at 1:00 PM ET as day-to-day with an illness. The report lists the detail as illness, other. It had no earlier status for him. The report's comment reads: "Coulibaly (illness) is questionable for Wednesday against the Hawks." The report gives an expected return of Nov. 4, the day of the game. No diagnosis beyond illness and no other timeline has been announced. Coulibaly is 22 years old.
What it means for the Wizards
Washington hosts the Hawks on Wednesday at 7:00 PM ET. The Wizards are 4-3, hold the fourth seed and have won two straight. Coulibaly has played in all seven games, averaging 27.3 minutes, 8.1 points, 3.6 rebounds and 0.7 assists. The Wizards are 4-3 with him and have not yet played a game without him. Who would absorb his minutes is not announced. The current rotation has Trae Young at 36.1 minutes, Anthony Davis at 33.5, Kyshawn George at 32.3, AJ Dybantsa at 30.0, Alex Sarr at 25.4 and Tre Johnson at 20.9. Justin Champagnie is out with a foot issue, and Sarr is day-to-day with a knee issue.
What to watch
The next update is his status before the 7:00 PM ET tip against the Hawks. The report lists his expected return as Nov. 4, which is the game date, but he is officially questionable. Watch whether Sarr, also day-to-day, is available, since the Wizards already have Champagnie, Reece Beekman, Tristan Vukcevic and Jamir Watkins out. No games beyond Atlanta are in focus yet.
Is Bilal Coulibaly playing vs the Hawks?
He is questionable for Wednesday's game against the Hawks at 7:00 PM ET. The injury report lists him as day-to-day with an illness, and the team has not announced a final decision.
When will Bilal Coulibaly be back?
The injury report lists an expected return of Nov. 4, the day of the Hawks game. He is questionable, and no longer timeline has been announced.